Undervalued Drug Manufacturer Stocks on TSE May 2024

May 25, 2024

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
VPH Valeo Pharma 0.10 0.23 138.26 75477 8 0.00 0.0
DN Delta 9 Cannabis 0.02 0.04 116.05 887776 5 0.00 0.0
AVNT Avant Brands 0.07 0.15 94.49 180160 20 0.00 0.0
CWEB Charlottes Web Holdings 0.24 0.45 88.08 60850 37 0.00 0.0
TLRY Tilray Brands 2.52 4.64 84.23 2745549 1901 0.00 0.0
TSND TerrAscend 2.15 2.96 37.66 285264 625 0.00 0.0
OGI OrganiGram Holdings 2.48 3.35 35.08 485062 226 0.00 0.0
LABS MediPharm Labs 0.08 0.10 25.00 252248 32 0.00 0.0
DHT.U DRI Healthcare Trust 11.01 13.60 23.54 381 621 2.82 5.5
MDP Medexus Pharma 1.63 1.94 19.32 36799 39 0.00 4.1
All data provided as at market close May 23, 2024.

Company Details

Valeo Pharma

VPH:TSX

Close Price

0.10

Our Valuation

0.23

% Difference

138.26

Market Cap ($M)

8

P/E Ratio

0.0

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Access the stockcalc valuation


Delta 9 Cannabis

DN:TSX

Close Price

0.02

Our Valuation

0.04

% Difference

116.05

Market Cap ($M)

5

P/E Ratio

0.0

Delta 9 Cannabis Inc is a cannabis company. It sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. The company owns and operates a chain of retail stores under the Delta 9 Cannabis store brand. Its reportable segments are Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business Business. It generates the majority of its revenue from the Retail Cannabis and Merchandise and Devices segment.

Access the stockcalc valuation


Avant Brands

AVNT:TSX

Close Price

0.07

Our Valuation

0.15

% Difference

94.49

Market Cap ($M)

20

P/E Ratio

0.0

Avant Brands Inc is an innovative premium cannabis company. It has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for highly desired, and award-winning consumer brands, sold across both recreational and medical channels. The company's diverse product range is distributed through three distinct sales channels: recreational, medical, and export.

Access the stockcalc valuation


Charlottes Web Holdings

CWEB:TSX

Close Price

0.24

Our Valuation

0.45

% Difference

88.08

Market Cap ($M)

37

P/E Ratio

0.0

Charlottes Web Holdings Inc is engaged in the production and distribution of hemp-based cannabidiol (CBD) wellness products. Its product categories include ingestible products (tinctures, capsules, and gummies), topicals, and pet products. The company distributes its products through an e-commerce website, third-party e-commerce websites, select distributors, health practitioners, and a variety of brick-and-mortar specialty retailers.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Tilray Brands

TLRY:TSX

Close Price

2.52

Our Valuation

4.64

% Difference

84.23

Market Cap ($M)

1901

P/E Ratio

0.0

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Access the stockcalc valuation


TerrAscend

TSND:TSX

Close Price

2.15

Our Valuation

2.96

% Difference

37.66

Market Cap ($M)

625

P/E Ratio

0.0

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.

Access the stockcalc valuation


OrganiGram Holdings

OGI:TSX

Close Price

2.48

Our Valuation

3.35

% Difference

35.08

Market Cap ($M)

226

P/E Ratio

0.0

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

Access the stockcalc valuation


MediPharm Labs

LABS:TSX

Close Price

0.08

Our Valuation

0.10

% Difference

25.00

Market Cap ($M)

32

P/E Ratio

0.0

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets.

Access the stockcalc valuation


DRI Healthcare Trust

DHT.U:TSX

Close Price

11.01

Our Valuation

13.60

% Difference

23.54

Market Cap ($M)

621

P/E Ratio

5.5

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties.

Access the stockcalc valuation


Medexus Pharma

MDP:TSX

Close Price

1.63

Our Valuation

1.94

% Difference

19.32

Market Cap ($M)

39

P/E Ratio

4.1

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Valeo Pharma and Delta 9 Cannabis are the most undervalued Drug Manufacturers stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-may-2024
Valeo Pharma $VPH and Delta 9 Cannabis $DN are the most undervalued Drug Manufacturers stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-may-2024
Valeo Pharma and Delta 9 Cannabis are the most undervalued Drug Manufacturers stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-tse-may-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.